CYT997

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Glioblastoma MultiformeRelapsed and Refractory Multiple Myeloma

Phase 1

Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma

TerminatedNCT00650949

Gilead SciencesGlioblastoma Multiforme

Start: 2009-11-30End: 2011-06-30Updated: 2013-05-03

Phase 2

Efficacy Study of CYT997 in Multiple Myeloma

TerminatedNCT00664378

Gilead SciencesRelapsed and Refractory Multiple Myeloma

Start: 2008-01-31End: 2011-02-28Updated: 2018-06-08